CHI Advisors’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $30.9M | Hold |
3,414,189
| – | – | 12.25% | 3 |
|
|
2023
Q2 | $36.7M | Buy |
3,414,189
+64,729
| +2% | +$696K | 11.15% | 4 |
|
|
2023
Q1 | $34.3M | Buy |
3,349,460
+31,916
| +1% | +$327K | 9.1% | 4 |
|
|
2022
Q4 | $35M | Buy |
3,317,544
+74,359
| +2% | +$784K | 9.32% | 5 |
|
|
2022
Q3 | $41.6M | Buy |
3,243,185
+195,576
| +6% | +$2.51M | 11.18% | 3 |
|
|
2022
Q2 | $39.1M | Buy |
3,047,609
+294,562
| +11% | +$3.78M | 14.92% | 2 |
|
|
2022
Q1 | $28.8M | Buy |
2,753,047
+276,327
| +11% | +$2.89M | 12.26% | 3 |
|
|
2021
Q4 | $38.2M | Buy |
2,476,720
+231,879
| +10% | +$3.58M | 12.68% | 3 |
|
|
2021
Q3 | $50.7M | Buy |
2,244,841
+2,000
| +0.1% | +$45.1K | 14.79% | 3 |
|
|
2021
Q2 | $57.8M | Buy |
2,242,841
+40,434
| +2% | +$1.04M | 13.44% | 4 |
|
|
2021
Q1 | $91.8M | Buy |
+2,202,407
| New | +$91.8M | 18.37% | 1 |
|